Epigral Ltd (EPIGRAL) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543332 | NSE: EPIGRAL | Chemicals | Small Cap

Epigral Share Price

1,471 -5.50 -0.37%
as on 05-Dec'25 15:23

Epigral Ltd (EPIGRAL) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543332 | NSE: EPIGRAL | Chemicals | Small Cap

DeciZen - make an informed investing decision on Epigral

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Epigral stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
15.84
Market Cap:
6,369.8 Cr.
52-wk low:
1,400
52-wk high:
2,195.9

Is Epigral Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Epigral: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Epigral Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 22.3%18.5%37.9%36.9%15.9%16.7%29.4%32.2%17.5%25.2%-
Value Creation
Index
0.70.41.81.70.20.21.11.30.30.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 3983925987106118291,5512,1881,9292,5502,467
Sales YoY Gr.--1.7%52.6%18.9%-14.1%35.7%87.2%41.1%-11.8%32.2%-
Adj EPS 9.59.32243.526.72460.484.146.380.693.2
YoY Gr.--1.4%135.2%97.8%-38.5%-10.1%151.3%39.4%-45%74.1%-
BVPS (₹) 41.751.173.168.489.7113.9174.7257.3301.8441.2486.8
Adj Net
Profit
6766.115517911199.8251350192348402
Cash Flow from Ops. 123138225261165229284626398441-
Debt/CF from Ops. 1.50.90.31.53.22.43.51.42.41.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 22.9%33.1%18%32.2%
Adj EPS 26.9%24.7%10.1%74.1%
BVPS30%37.5%36.2%46.2%
Share Price - - 5.6% -30.8%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
2620.135.435.420.615.835.63916.62220.1
Op. Profit
Mgn %
37.436.842.743.931.831.532.931.52527.926.4
Net Profit
Mgn %
16.816.92625.218.212.116.2161013.616.3
Debt to
Equity
0.60.30.10.80.90.81.40.80.80.30.2
Working Cap
Days
8181757984777569878553
Cash Conv.
Cycle
2435282534264041403616

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Epigral Ltd.

Standalone Consolidated
TTM EPS (₹) 93.2 93.3
TTM Sales (₹ Cr.) 2,467 2,467
BVPS (₹.) 486.8 487
Reserves (₹ Cr.) 2,057 2,058
P/BV 3.03 3.03
PE 15.84 15.83
From the Market
52 Week Low / High (₹) 1400.00 / 2195.85
All Time Low / High (₹) 386.35 / 2408.35
Market Cap (₹ Cr.) 6,370
Equity (₹ Cr.) 43.1
Face Value (₹) 10
Industry PE 48.1

Management X-Ray of Epigral:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Epigral - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Epigral

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales3983925987106118291,5512,1881,9292,550
Operating Expenses 2492473423994165671,0411,4991,4481,839
Manufacturing Costs404048385270163234227274
Material Costs1801732382552753857611,1151,0611,353
Employee Cost 12141621334152698198
Other Costs 172140835771658279114
Operating Profit 149144255312194261509689481711
Operating Profit Margin (%) 37.4%36.8%42.7%43.9%31.8%31.5%32.9%31.5%24.9%27.9%
Other Income 214149789715
Interest 1914930173448677353
Depreciation 44555554447486109124133
Exceptional Items 0000000000
Profit Before Tax 8875195242141161383523291540
Tax 2194059296013116995183
Profit After Tax 6767155183112101253353196357
PAT Margin (%) 16.9%17.0%26.0%25.7%18.3%12.2%16.3%16.1%10.1%14.0%
Adjusted EPS (₹)9.59.422.044.427.024.360.885.047.182.7
Dividend Payout Ratio (%)0%0%0%0%0%0%0%6%11%7%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 2953625174935836847261,0691,2541,904
Share Capital 71717125225225242424243
Reserves 2242914472413314326841,0281,2131,860
Minority Interest0000000000
Debt1236034368438416848636768498
Long Term Debt113451365418340768545547449
Short Term Debt9153322075809222150
Trade Payables27183336477388110184186
Others Liabilities 958279147204276461617588564
Total Liabilities 5405226631,0441,2731,4492,1242,4322,7943,151

Fixed Assets

Gross Block4084974984996881,4241,4752,3202,4062,953
Accumulated Depreciation4499150204248321407516639715
Net Fixed Assets 3643983472954401,1021,0681,8041,7672,238
CWIP 6937946869112658915848364
Investments 029710000212197
Inventories372830414854154212263388
Trade Receivables4644777776119256166179232
Cash Equivalents 105129012515722
Others Assets 232054341647315676110
Total Assets 5405226631,0441,2731,4492,1242,4322,7943,151

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 123138225261165229284626398441
PBT 8875195242141161383523291540
Adjustment 6473617056103130170196178
Changes in Working Capital -111078-4-6-16941-38-167
Tax Paid -17-20-38-59-28-29-60-107-51-110
Cash Flow From Investing Activity -40-63-167-217-363-197-455-437-401-262
Capex -59-35-122-303-369-197-456-416-398-186
Net Investments 18-28-112822-01-1-3-75
Others 00684400-2000
Cash Flow From Financing Activity -83-76-588569-32195-200-8-164
Net Proceeds from Shares 0001500000333
Net Proceeds from Borrowing -7000350110-47239-6417-112
Interest Paid -22-14-9-9-37-40-48-60-72-66
Dividend Paid 000-3000-10-10-32
Others 9-62-49-268-4544-6558-288
Net Cash Flow -0-0-0129-129124-11-1115

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)26.2720.2635.3745.7534.2323.8542.1639.3716.8522.59
ROCE (%)22.2718.4537.9236.8815.916.7429.432.217.525.22
Asset Turnover Ratio0.830.841.040.850.550.630.91.020.770.91
PAT to CFO Conversion(x)1.842.061.451.431.472.271.121.772.031.24
Working Capital Days
Receivable Days36373639444243333128
Inventory Days23271718262224294344
Payable Days54483950555739325150

Epigral Ltd Stock News

Epigral Ltd FAQs

The current trading price of Epigral on 05-Dec-2025 15:23 is ₹1,471.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Epigral stood at ₹6,369.8.
The latest P/E ratio of Epigral as of 04-Dec-2025 is 15.84.
The latest P/B ratio of Epigral as of 04-Dec-2025 is 3.03.
The 52-week high of Epigral is ₹2,195.9 and the 52-week low is ₹1,400.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Epigral is ₹2,467 ( Cr.) .

About Epigral Ltd

Meghmani Finechem Limited (MFL) is a Public Company limited by shares domiciled in India, incorporated under the provisions of Companies Act, 1956. The registered office of the company is located at GIDC Industrial Estate, Dahej, Tal. Vagara, Dist. Bharuch, Gujarat.

It is an ISO 9001 and ISO 14001-certified company founded in 2007 and recognised as one of the leading producers of chlor alkali and its Derivatives with backward and forward integration facilities. The Company meets the global essential chemicals demand with responsible care and with large-scale growth, while committing to quality and environment integrity.

MFL works out of an advanced automated production facility, which is equipped to address international standards in the manufacture of Caustic Soda, Caustic Potash, Chlorine, Hydrogen, Chloromethanes and Hydrogen Peroxide. The Company aims to service domestic as well as export markets, contributing towards the ‘Make in India’ initiative.

Business area of the company

The Company is primarily engaged in manufacturing and selling of Chlor Alkali & its Derivatives. The Company is also engaged in Trading of Agrochemical products.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×